公开(公告)号：US5989556A

公开(公告)日：1999-11-23

申请号：US890065

申请日：1997-07-09

申请人： Hsiu-Hsien Tsai ,  Shie-Ming Hwang

发明人： Hsiu-Hsien Tsai ,  Shie-Ming Hwang

IPC分类号： A61K36/00 ,  A61K9/20 ,  A61K9/48 ,  A61K36/28 ,  A61K36/48 ,  A61K36/539 ,  A61K36/638 ,  A61K36/81 ,  A61P31/12 ,  A61P31/18 ,  A61K35/78

CPC分类号： A61K36/00 ,  A61K36/28 ,  A61K36/48 ,  A61K36/638 ,  A61K36/81 ,  A61K9/20 ,  A61K9/48 ,  Y10S514/885 ,  Y10S514/894 ,  Y10S514/895

摘要： Compositions derived from Chinese herbal medicines, medicinal plants and extracts thereof, are provided for the treatment of animals infected with viruses, especially with hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV). More specifically, the compositions of the present invention are derived from various Chinese herbal medicines or medicinal plants which have a long history of human consumption. The compositions of the invention are obtained through specific techniques and have demonstrated outstanding efficacy for treating human HBV carriers and hepatitis C patients. Compositions according to the invention have also exhibited in vitro antiviral activities against murine leukemia virus (MuLV) and HIV. HIV is the virus known to cause acquired immunodeficiency syndrome (AIDS) in humans and AIDS presents special problems to the medical community which the present invention addresses. Preferred compositions contain the herbal ingredients AEGINETIAE HERBA, BLECHNI RHIZOMA, LESPEDEZAE HERBA, POLYGONI CUSPIDATI RHIZOMA, FORSYTHIAE FRUCTUS, and LIGUSTRI FRUCTUS, or contain the herbal ingredients AEGINETIAE HERBA, LONICERAE FLOS, PRUNELLAE SPICA, and LESPEDEZAE HERBA.

摘要翻译： 提供中草药成分，药用植物及其提取物，用于治疗感染病毒的动物，特别是乙型肝炎病毒（HBV），丙型肝炎病毒（HCV）和人类免疫缺陷病毒（HIV）。 更具体地说，本发明的组合物衍生自具有长期人类消费历史的各种中草药或药用植物。 通过具体技术获得本发明的组合物，并且已经证明了治疗人HBV携带者和丙型肝炎患者的突出功效。 根据本发明的组合物还显示针对鼠白血病病毒（MuLV）和HIV的体外抗病毒活性。 艾滋病毒是已知会导致人类获得性免疫缺陷综合征（AIDS）的病毒，艾滋病对本发明所涉及的医疗社区具有特殊问题。 优选的组合物含有草药成分AEGINETIAE HERBA，BLECHNI RHIZOMA，LESPEDEZAE HERBA，POLYGONI CUSPIDATI RHIZOMA，FORSYTHIAE FRUCTUS和LIGUSTRI FRUCTUS，或含有草药成分AEGINETIAE HERBA，LONICERAE FLOS，PRUNELLAE SPICA和LESPEDEZAE HERBA。

公开(公告)号：US09789153B2

公开(公告)日：2017-10-17

申请号：US14321839

申请日：2014-07-02

申请人： Hsiu-Hsien Tsai

发明人： Hsiu-Hsien Tsai

IPC分类号： A61K36/9066 ,  A61K36/536 ,  A61K36/539 ,  A61K36/07 ,  A61K36/65 ,  A61K36/84 ,  A61K36/288 ,  A23L33/10 ,  A23L33/105 ,  A61K9/19

CPC分类号： A61K36/9066 ,  A23L33/10 ,  A23L33/105 ,  A23V2002/00 ,  A61K9/19 ,  A61K36/07 ,  A61K36/288 ,  A61K36/536 ,  A61K36/539 ,  A61K36/65 ,  A61K36/84 ,  A61K2300/00 ,  A23V2200/308 ,  A23V2250/21

摘要： This invention relates to a composition derived from Chinese herbal medicines, medicinal plants and extracts thereof, and to its use for preventing cancer and treating cancer and intensifying the effects of other anticancer drugs. More specifically, the composition of the present invention is derived from various Chinese herbal medicines or medicinal plants which have a long history of human consumption. The composition of the invention is obtained through specific techniques and has revealed good cytotoxicities on Malignant Melanoma Cells, Prostate Cancer Cells and Colon Cancer Cells, Lung Cancer Cells, Stomach Cancer Cells, Breast Cancer Cells and Liver Cancer Cells. The composition of the invention has also revealed obvious intensifying the effects of other anticancer drugs. Cancer presents special problems to the medical community which the present invention address.

公开(公告)号：US20160000856A1

公开(公告)日：2016-01-07

申请号：US14321839

申请日：2014-07-02

申请人： Hsiu-Hsien Tsai

发明人： Hsiu-Hsien Tsai

IPC分类号： A61K36/9066 ,  A61K36/539 ,  A61K36/28 ,  A61K36/65 ,  A61K36/35 ,  A61K36/536 ,  A61K36/07

CPC分类号： A61K36/9066 ,  A23L33/10 ,  A23L33/105 ,  A23V2002/00 ,  A61K9/19 ,  A61K36/07 ,  A61K36/288 ,  A61K36/536 ,  A61K36/539 ,  A61K36/65 ,  A61K36/84 ,  A61K2300/00 ,  A23V2200/308 ,  A23V2250/21

摘要： This invention relates to a composition derived from Chinese herbal medicines, medicinal plants and extracts thereof, and to its use for preventing cancer and treating cancer and intensifying the effects of other anticancer drugs. More specifically, the composition of the present invention is derived from various Chinese herbal medicines or medicinal plants which have a long history of human consumption. The composition of the invention is obtained through specific techniques and has revealed good cytotoxicities on Malignant Melanoma Cells, Prostate Cancer Cells and Colon Cancer Cells, Lung Cancer Cells, Stomach Cancer Cells, Breast Cancer Cells and Liver Cancer Cells. The composition of the invention has also revealed obvious intensifying the effects of other anticancer drugs. Cancer presents special problems to the medical community which the present invention address,

摘要翻译： 本发明涉及中草药衍生物，药用植物及其提取物，以及其用于预防癌症和治疗癌症以及增强其它抗癌药物的作用的用途。 更具体地说，本发明的组合物来源于人类消费历史悠久的各种中草药或药用植物。 通过特定技术获得本发明的组合物，并且已经在恶性黑素瘤细胞，前列腺癌细胞和结肠癌细胞，肺癌细胞，胃癌细胞，乳腺癌细胞和肝癌细胞中显示出良好的细胞毒性。 本发明组合物也显示出明显加剧其他抗癌药物的作用。 癌症对本发明所涉及的医学界存在特殊问题，

公开(公告)号：US5837257A

公开(公告)日：1998-11-17

申请号：US863803

申请日：1997-05-27

申请人： Hsiu-Hsien Tsai ,  Shie-Ming Hwang ,  Pai-Chu Kung

发明人： Hsiu-Hsien Tsai ,  Shie-Ming Hwang ,  Pai-Chu Kung

IPC分类号： A61K36/00 ,  A61K9/20 ,  A61K9/48 ,  A61K36/28 ,  A61K36/48 ,  A61K36/539 ,  A61K36/638 ,  A61K36/81 ,  A61P31/12 ,  A61P31/18 ,  A61K35/78

CPC分类号： A61K36/00 ,  A61K36/28 ,  A61K36/48 ,  A61K36/638 ,  A61K36/81 ,  A61K9/20 ,  A61K9/48 ,  Y10S514/885 ,  Y10S514/894 ,  Y10S514/895

摘要： This invention relates to compositions derived from Chinese herbal medicines, medicinal plants and extracts thereof, and to their use for the treatment of animals infected with viruses, especially with hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV). More specifically, the compositions of the present invention are derived from various Chinese herbal medicines or medicinal plants which have a long history of human consumption. The compositions of the invention are obtained through specific techniques and have demonstrated outstanding efficacy for treating human HBV carriers and hepatitic C patients. Compositions according to the invention have also exhibited in vitro antiviral activities against murine leukemia virus (MuLV) and HIV. HIV is the virus known to cause acquired immunodeficiency syndrome (AIDS) in humans and AIDS presents special problems to the medical community which the present invention addresses.

摘要翻译： 本发明涉及中草药衍生物，药用植物及其提取物，以及用于治疗感染病毒，特别是乙型肝炎病毒（HBV），丙型肝炎病毒（HCV）和人类免疫缺陷病毒 （HIV）。 更具体地说，本发明的组合物衍生自具有长期人类消费历史的各种中草药或药用植物。 通过特定技术获得本发明的组合物，并且已经证明了治疗人类HBV携带者和肝癌C患者的突出功效。 根据本发明的组合物还显示针对鼠白血病病毒（MuLV）和HIV的体外抗病毒活性。 艾滋病毒是已知会导致人类获得性免疫缺陷综合征（AIDS）的病毒，艾滋病对本发明所涉及的医疗社区具有特殊问题。

公开(公告)号：US5776462A

公开(公告)日：1998-07-07

申请号：US761321

申请日：1996-12-10

申请人： Hsiu-Hsien Tsai ,  Shie-Ming Hwang

发明人： Hsiu-Hsien Tsai ,  Shie-Ming Hwang

IPC分类号： A61K9/20 ,  A61K9/68 ,  A61K36/53 ,  A61K36/532 ,  A61K47/00 ,  A61P11/04 ,  A61P31/04 ,  A61K35/78

CPC分类号： A61K36/53 ,  A61K36/532 ,  Y10S514/888

摘要： The attachment of H. influenzae to human cells such as oropharyngeal cells, is inhibited by aqueous extracts of the plants known as Pogostemon cablin and Agastache rugosa. The composition obtained from the aqueous extraction of the plants Pogostemon cablin, Agastache rugosa or mixtures thereof is also effective in preventing or treating Otitis media and sore throat. The plant extract may be contained in a liquid enteral product such as an infant formula or may be incorporated into lozenges, candies, chewing gums and the like. The plant extract may also be administered as a throat spray or nasally using drops or a spray. A process for the production of a medicinal product is also disclosed.

摘要翻译： 流感嗜血杆菌对人细胞如口咽细胞的附着被称为Pogostemon cablin和Agastache rugosa的植物的水提取物抑制。 从植物Pogostemon cablin，藿香或其混合物的水提取物获得的组合物也可有效预防或治疗中耳炎和喉咙痛。 植物提取物可以包含在液体肠内产品如婴儿配方奶粉中，或者可以掺入锭剂，糖果，口香糖等中。 植物提取物也可以使用滴剂或喷雾剂作为咽喉喷雾剂或鼻腔给药。 还公开了用于生产药用产品的方法。